Davenport & Co’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-17,538
| Closed | -$823K | – | 618 |
|
|
2015
Q3 | $823K | Sell |
17,538
-36,976
| -68% | -$1.73M | 0.01% | 301 |
|
|
2015
Q2 | $3.4M | Buy |
54,514
+36,826
| +208% | +$2.3M | 0.05% | 172 |
|
|
2015
Q1 | $1.09M | Sell |
17,688
-4,012
| -18% | -$248K | 0.02% | 284 |
|
|
2014
Q4 | $1.17M | Sell |
21,700
-408
| -2% | -$22K | 0.02% | 268 |
|
|
2014
Q3 | $1.17M | Sell |
22,108
-252
| -1% | -$13.4K | 0.02% | 256 |
|
|
2014
Q2 | $1.16M | Sell |
22,360
-23,146
| -51% | -$1.2M | 0.02% | 257 |
|
|
2014
Q1 | $2.13M | Buy |
45,506
+17,672
| +63% | +$827K | 0.04% | 198 |
|
|
2013
Q4 | $1.22M | Hold |
27,834
| – | – | 0.02% | 241 |
|
|
2013
Q3 | $1.07M | Buy |
27,834
+1,474
| +6% | +$56.7K | 0.02% | 243 |
|
|
2013
Q2 | $929K | Buy |
+26,360
| New | +$929K | 0.02% | 232 |
|